Unavailable Lorem ornare arcu a velit sodales elementum. Drama tempor magna at lectus sodales, a vehicula leo vulputate. Suspendisse sed pharetra mauris, pulvinar efficitur.
Unavailable Lorem ornare arcu a velit sodales elementum. Drama tempor magna at lectus sodales, a vehicula leo vulputate. Suspendisse sed pharetra mauris, pulvinar efficitur.
Unavailable Lorem ornare arcu a velit sodales elementum. Drama tempor magna at lectus sodales, a vehicula leo vulputate. Suspendisse sed pharetra mauris, pulvinar efficitur.
Unavailable Lorem ornare arcu a velit sodales elementum. Drama tempor magna at lectus sodales, a vehicula leo vulputate. Suspendisse sed pharetra mauris, pulvinar efficitur.
For the President to maintain popularity and be humankind’s hero, he must deploy the vaccine for most of the world without a hitch.
With little hope for the amateur spy, a federal agent then tries to turn a Genyologen employee into an asset.
The espionage has brought suspicion from the outset. Under test, the inside agent must find a cure before he succumbs to the deadly virus.
Corporate spy, Ray Zy-Dyent, interviews at a major pharmaceutical competitor to access incriminating evidence for the government.
The government recruits a scientist to go undercover as a spy to gather information about a serum to cure the rampant disease.
The largest pharma-tech company weighs the advantages of a consortium to battle a global health crisis.
A major entity within the pharmaceutical consortium discusses ramifications of the Presidents’s international speech.
Premiere: As the year 2100 approaches, this world teeters on the edge of a new era—or human extinction in this novella miniseries.
Listen to events during the year 2067, technology overtakes essential services to bend reality in this sci-fi novella miniseries.
Featured authors and reviewers
This information does not constitute professional medical care or legal advice. Discuss personal concerns with your doctor or legal advisor.